HBX, formerly known as Hotelbeds, marks its first anniversary on the stock market on a somber note, having lost approximately 33% of its value since its debut. Initially launched at 11.5 euros per share, HBX is now trading at 7.77 euros, illustrating significant volatility over the year. This downturn contrasts sharply with the booming global tourism sector and the overwhelming support from analysts who continue to see promise in the company's future.

Despite the stock price decline, all 13 firms tracking HBX are recommending a buy, suggesting a strong belief in the company's long-term potential. The average target price set by these analysts is 13.34 euros per share, indicating a possible upside of around 72% from its current trading status. This wide gap between the current price and analyst targets signals an interesting situation for investors who might see an opportunity to buy at a lower price while expecting a rebound.

The first year for HBX was also marked by a significant turning point when the company revised its forecasts downward in the third quarter, which may have contributed to the stock's downward trajectory. The juxtaposition of a thriving tourism industry against the company's struggling share price raises questions about market perceptions and internal strategies at HBX. As the company looks to the future, the combination of analyst confidence and market challenges will be crucial in determining its trajectory moving forward.